Anticoagulant therapy for cancer-associated splanchnic vein thrombosis: Outcomes during a one-year follow-up period
- 27 July 2025
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 253, 109411
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Management and outcomes in patients with tumor thrombus: a retrospective cohort studyJournal of Thrombosis and Haemostasis, 2024
- Natural history of cancer-associated splanchnic vein thrombosisJournal of Thrombosis and Haemostasis, 2024
- Breaking down tumor thrombus: Current strategies for medical managementThrombosis Research, 2023
- Baveno VII – Renewing consensus in portal hypertensionJournal of Hepatology, 2022
- Splanchnic vein thrombosis: Clinical manifestations, risk factors, management, and outcomesThrombosis Research, 2021
- Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver DiseasesHepatology, 2020
- Splanchnic vein thrombosis predicts worse survival in patients with advanced pancreatic cancerThrombosis Research, 2020
- Epidemiology of Budd-Chiari syndrome: A systematic review and meta-analysisClinics and Research in Hepatology and Gastroenterology, 2019
- Long-term Clinical Outcomes of Splanchnic Vein ThrombosisJAMA Internal Medicine, 2015
- Clinical approach to splanchnic vein thrombosis: Risk factors and treatmentThrombosis Research, 2012